What is he best known for?
The fields of study he is best known for:
- Enzyme
- Internal medicine
- Gene
His primary areas of investigation include Biochemistry, Chromatography, Internal medicine, Endocrinology and Endocannabinoid system.
His Biochemistry study combines topics in areas such as Cell culture, 4-Butyrolactone, In vivo and Pseudomonadaceae.
His Chromatography research focuses on Mass spectrometry in particular.
His Internal medicine study frequently involves adjacent topics like Gastroenterology.
The various areas that David A. Barrett examines in his Endocrinology study include Tetrahydrocannabivarin, Palmitoylethanolamide and Spinal cord.
David A. Barrett combines subjects such as Cannabinoid and Cannabinoid receptor with his study of Endocannabinoid system.
His most cited work include:
- Sustained translational repression by eIF2α-P mediates prion neurodegeneration (409 citations)
- Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice (384 citations)
- Glutathione S-transferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli (236 citations)
What are the main themes of his work throughout his whole career to date?
David A. Barrett mostly deals with Chromatography, Internal medicine, Pharmacology, Biochemistry and Endocrinology.
His work in Internal medicine addresses issues such as Gastroenterology, which are connected to fields such as Antibiotics.
His Pharmacology research includes elements of Anesthesia, Cannabinoid and AM251, Cannabinoid receptor.
His Cannabinoid research incorporates elements of Anandamide and Fatty acid amide hydrolase.
His work on Endocrinology is being expanded to include thematically relevant topics such as Endocannabinoid system.
His High-performance liquid chromatography research incorporates themes from Metabolite and Extraction.
He most often published in these fields:
- Chromatography (22.45%)
- Internal medicine (16.03%)
- Pharmacology (13.70%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (16.03%)
- Pharmacology (13.70%)
- Endocrinology (8.75%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Pharmacology, Endocrinology, Chromatography and Biochemistry.
While the research belongs to areas of Internal medicine, he spends his time largely on the problem of Gastroenterology, intersecting his research to questions surrounding Gut flora.
His Pharmacology study frequently draws parallels with other fields, such as Receptor.
In general Chromatography study, his work on Reproducibility, Tandem mass spectrometry and Hydrophilic interaction chromatography often relates to the realm of Thiamine pyrophosphate, thereby connecting several areas of interest.
Mitochondrion, Cannabinoid receptor and Fatty acid amide hydrolase are among the areas of Biochemistry where the researcher is concentrating his efforts.
His work deals with themes such as Quorum sensing, Pseudomonas aeruginosa and Quinolone, which intersect with Cystic fibrosis.
Between 2016 and 2021, his most popular works were:
- Repurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in mice. (130 citations)
- RECAST (Remote Ischemic Conditioning After Stroke Trial): A Pilot Randomized Placebo Controlled Phase II Trial in Acute Ischemic Stroke. (67 citations)
- Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα (46 citations)
In his most recent research, the most cited papers focused on:
- Enzyme
- Internal medicine
- Gene
David A. Barrett mainly investigates Internal medicine, Endocrinology, Inflammation, Biochemistry and Pharmacology.
He has researched Internal medicine in several fields, including Gastroenterology, Feces, Inulin and Immunology.
The study incorporates disciplines such as Monoacylglycerol lipase, Intestinal mucosa, Oxylipin and C-reactive protein in addition to Endocrinology.
The various areas that he examines in his Inflammation study include Synovitis and Metabolic syndrome.
His research in Pharmacology intersects with topics in Unfolded protein response, Neurodegeneration and Translational attenuation.
David A. Barrett works mostly in the field of Cannabinoid, limiting it down to concerns involving N-Acylethanolamine and, occasionally, Anandamide and Endocannabinoid system.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
